The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Weekly nab-paclitaxel in combination with cisplatin as neoadjuvant chemotherapy in patients (pts) with locally advanced esophageal squamous cell carcinoma (SCC): Preliminary results of a phase study.
Youhua Jiang
No relevant relationships to disclose
Fan Yun
No relevant relationships to disclose
Qixun Chen
No relevant relationships to disclose
Xinming Zhou
No relevant relationships to disclose
Zhiyu Huang
No relevant relationships to disclose
Lei Gong
No relevant relationships to disclose
Haiyan Yang
No relevant relationships to disclose
Haifeng Yu
No relevant relationships to disclose
Jinshi Liu
No relevant relationships to disclose
Pengcheng Chen
No relevant relationships to disclose
Qiang Zhao
No relevant relationships to disclose
Weimin Mao
No relevant relationships to disclose